At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 112 enrolled
Drug / intervention
Gabapentin +1 moredrug
Likely dose
Gabapentin 300mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Administration of Pre-Operative Gabapentin to Patients Undergoing Laparoscopy: A Prospective Double-blinded, Placebo Controlled Randomized Study
In Brief
A Phase 4 clinical trial evaluating Gabapentin and Placebo for Postoperative Pain. Completed, enrolled 112 participants across 1 site.
Detailed Summary
The purpose of this study is to prospectively determine the influence of immediate pre-operative gabapentin administration on acute postoperative pain. The investigators hypothesize that immediate post-operative pain will be improved with pre-operative administration of gabapentin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Pain
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 2015
Enrollment StartJun 2015
Primary CompletionJan 2017
TodayJul 2026
First PostedFeb 9, 2015
Enrollment StartJun 1, 2015
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 11.4 years ago
Interventions
Gabapentindrug
Patients will receive Gabapentin 300mg tab less than 1 hour before surgery.
Placeboother
Patient will receive placebo tab less than 1 hour before surgery